Skip to content

Clinical trials

Observational Parkinson Disease trials in Switzerland

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Parkinson Disease Phase: Observational Country / region: Switzerland Clear all

17 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20062
20131
20141
20151
20161
20191
20201
20212
20233
20242
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Recruiting3
Active, not recruiting2
Unknown status2
Not yet recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Insel Gruppe AG, University Hospital Bern3
University Hospital, Geneva3
AbbVie2
Boehringer Ingelheim1
Centre Hospitalier Universitaire Vaudois1
Christian Baumann1
Neurocenter of Southern Switzerland1
Salvatore Galati1
Swiss Federal Institute of Technology1
UCB Pharma1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Parkinson Disease17
Lethargy2
Disruptive, Impulse Control, and Conduct Disorders1
Dysarthria1
Dyskinesias1
Fatigue1
Gait Disorders, Neurologic1
Hypotension, Orthostatic1
Mental Disorders1

Trials

Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.